• Explore /
  • Poster
  • / CA125 kinetics as a potential biomarker of prognosis in nivolumab monotherapy for patients with advanced gastric cancer and peritoneal metastasis.

CA125 kinetics as a potential biomarker of prognosis in nivolumab monotherapy for patients with advanced gastric cancer and peritoneal metastasis.

Abstract Poster

Authors

null

Takayuki Ando

Third Department of Internal Medicine, University of Toyama, Toyama, Japan;

Takayuki Ando , Satoshi Yuki , Yosuke Kito , Akira Ueda , Iori Motoo , Ken Ito , Miho Sakumura , Yuko Ueda , Shinya Kajiura , Naokatsu Nakada , Koji Nakajima , Ayumu Hosokawa , Kazuaki Harada , Yasuyuki Kawamoto , Yoshito Komatsu , Ichiro Yasuda

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cancers of the Esophagus and Stomach and Other GI Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Tumor Biology, Biomarkers, and Pathology

Citation

J Clin Oncol 41, 2023 (suppl 4; abstr 445)

DOI

10.1200/JCO.2023.41.4_suppl.445

Abstract #

445

Poster Bd #

K11

Abstract Disclosures

Similar Posters

First Author: Ian Chau

First Author: Yusuke Amanuma

First Author: Sylvie Lorenzen

First Author: Akira Ueda